Neuropsychiatric lupus: Getting beyond the barrier of the brain

Lupus

Volumn 5, Issue 3, 1996, Pages 173-174

  Mevorach, D ^a   Elkon, Kb ^a  

^a WEILL CORNELL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; CYTOKINE;

BIOSYNTHESIS; BRAIN; EDITORIAL; HUMAN; IMMUNOLOGY; MENTAL DISEASE; METABOLISM; SYSTEMIC LUPUS ERYTHEMATOSUS;

AUTOANTIBODIES; BRAIN; CYTOKINES; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MENTAL DISORDERS;

EID: 0030157660     PISSN: 09612033     EISSN: None     Source Type: Journal    
DOI: 10.1177/096120339600500301     Document Type: Editorial

References (32)

1. Boumpas DT et al. Systemic lupus erythematosus: emerging concepts. Ann Int Med 1995; 122: 940-950.
2. Kent DL, Haynor DR, Longstreth WT Jr, Larson EB The clinical efficacy of magnetic resonance imaging in neuroimaging. Ann Int Med 1994; 120: 856-871.
3. Sibbitt WL Jr et al. Spin-spin relaxation of brain tissues in systemic lupus erythematosus. Arthritis Rheum 1995; 38: 810-818.
4. Kovacs Jaj, Urowitz MB, Gladman DD, Zeman R. The use of single photon emission computerized tomography in neuropsychiatric SLE: a pilot study. J Rheumatol 1995; 22: 1247-1253.
5. Kodama K. et al. Single photon emission computed tomography in systemic lupus erythematosus with psychiatric symptoms. J Neurol Neurosurg Psych 1995; 58: 307-311.
6. Colamussi P. et al. Brain single-photon emission tomography with 99mTc-HMPAO in neuropsychiatric systemic lupus erythematosus: relations with EEG and MRI findings and clinicial manifestations. Eur J Nucl Med 1995; 22: 17-24.
7. Stoppe G. et al. Positron emission tomography in neuropsychiatric lupus erythematosus. Neurol 1990; 40: 304.
8. Carbotte RM, Denburg SD, Denburg JA, Nahmias C., Garnett ES Glucose metabolism in neuropsychiatric systemic lupus erythematosus. J Neurol Neurosurg Psych 1992; 55: 1054-1059.
9. Belmont HM, Abramson SB, Lie JT Pathology and pathogenesis of vascular injury in systemic lupus erythematosus. Arthritis Rheuum 1996; 39(1): 9-22.
10. Brey RL, Gharavi AE, Lockshin MD Neurologic complication of antiphospholipid antibodies. In: Elkon KB (ed), Neurologic Aspects of Rheumatic Diseases. Rheum Dis Clin No Am 1933; 19: 833-850.
11. Toubi E., Khamashta MA, Panarra A., Hughes Grv. Association of antiphospholipid antibodies with central nervous system disease in systemic lupus erythematosus. Am J Med 1995; 99: 387.
12. Bluestein HG The central nervous system in systemic lupus erythematosus. In: Lahita RD (ed), Systemic Lupus Erythematosus, Churchill, Livingstone: New York, 1992, pp 639-655.
13. Bonfa E. et al. Association between lupus psychosis and antiribosomal P protein antibodies: measurement of antibody using a synthetic peptide antigen. N Engl J Med 1987; 317: 255-271.
14. Pereira RM, Yoshinari NH, De Oliveira RM, Cossermelli W. Antiganglioside antibodies in patients with neuropsychiatric systemic lupus erythematosus. Lupus 1992; 1: 175-179.
15. Hanly JG, Hong C., White TD Brain synaptosomal antibodies in systemic lupus erythematosus. Lupus 1993; 2: 35-45.
16. Watanabe T., Sato T., Uchiumi T., Arakawa M. Neuropsychiatric manifestations in patients with systemic lupus erythematosus: diagnostic and predictive value of longitudinal examination of antiribosomal P antibody. Lupus 1996; 5: 178-183.
17. Bonfa E., Chu JL, Brot N., Elkon K. Lupus antiribosomal antibodies show limited heterogeneity and are predominantly of the IgG1 and IgG2 subclasses. Clin Immunol Immunopathol 1987; 45: 129-138.
18. Sonoda E. et al. Differential regulation of IgA production by TGF-β induces surface IgA-positive cells bearing IL-5 receptor, whereas IL-5 promotes their survival and maturation into IgAsecreting cells. Cell Immunol 1992; 140: 158-172.
19. McIntyre TM, Kehry MR, Snapper CM Novel in vitro model for high-rate IgA class switching. J Immunol 1995; 154: 3156-3161.
20. Ohman S., Emerudh J., Roberg M., Forsberg P. Determination of total and herpes simplex virus-specific monomeric and dimeric IgA in serum and cerobrospinal fluid by ultracentrifugation. Ann Clin Biochem 1995; 32: 550-556.
21. Koren E., Reichlin MW, Kossel M., Fugate RD, Reichlin M. Autoantibodies to the ribosomal P proteins react with a plasma membrane-related target on human cells. J Clin Invest 1992; 89: 1236-1241.
22. Gaburo N. Jr et al. In vivo effects of antiribosomal P protein antibody injections into the lateral ventricle of the rat brain. Arthritis Rheum 1995; 38: S297.
23. Golombek SJ, Graus F., Elkon KB Autoantibodies in the cerobrospinal fluid of patients with systemic lupus erythematosus. Arthritis Rheum 1986; 29: 1090-1097.
24. Mevorach D., Raz E., Steiner I. Evidence for intrathecal synthesis of autoantibodies in systemic lupus erythematosus with neurological involvement. Lupus 1994; 3: 117-121.
25. Mevorach D. et al. Intrathecal synthesis of autoantibodies in patients with neuropsychiatric lupus. Arthritis Rheum 1996; 38: S301.
26. Hickey WF, Hsu BL, Kimura H. T lymphocyte entry into the central nervous system. J Neurosci Res 1991; 28: 254-260.
27. Hirohata S., Miyamoto T. Elevated levels of interleukin-6 in cerobrospinal fluid from patients with systemic lupus erythematosus and central nervous system involvement. Arthritis Rheum 1990; 33: 644-649.
28. Isshi K., Hirohata S., Hashimoto T., Miyashita H. Systemic lupus erythematosus presenting with diffuse low density lesions in the cerebral white matter on computed axial tomography scans: its implication in the pathogenesis of diffuse central nervous system lupus. J Rheumatol 1994; 21: 1758-1762.
29. Sebire G. et al. In vitro production of IL-6, IL-1β, and tumor necrosis factor-α by human embryonic microglial and neural cells. J Immunol 1993; 150: 1517-1523.
30. Fabry Z. et al. Production of the cytokines interleukin-1 and 6 by murine brain microvessel endothelium and smooth muscle pericytes. J Neuroimmunol 1993; 47: 23-34.
31. Hunter CA, Abrams JS, Beaman MH, Remington JS Cytokine mRNA in the central nervous system of SCID mice infected with Toxoplasma gondii: importance of T cell-independent regulation of resistance to T Gondii. Infect Immun 1993; 61: 4038-4044.
32. Campbell IL et al. Neurologic disease induced in transgenic mice by cerebral overexpression of interleukin-6. Proc Natl Acad Sci, USA 1993; 90: 10061-10065.